These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17606621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C, Lovenberg TW.
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
    Hossain MA, Bathgate RA, Rosengren KJ, Shabanpoor F, Zhang S, Lin F, Tregear GW, Wade JD.
    Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
    [Abstract] [Full Text] [Related]

  • 5. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW, Liu C.
    Neuroendocrinology; 2005 Jan; 82(3-4):139-50. PubMed ID: 16679775
    [Abstract] [Full Text] [Related]

  • 6. Recent progress in relaxin-3-related research.
    Liu C, Bonaventure P, Sutton SW, Chen J, Kuei C, Nepomuceno D, Lovenberg TW.
    Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
    [Abstract] [Full Text] [Related]

  • 7. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C, Chen J, Kuei C, Sutton S, Nepomuceno D, Bonaventure P, Lovenberg TW.
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [Abstract] [Full Text] [Related]

  • 8. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.
    Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, Nepomuceno D, Lovenberg TW, Liu C.
    Neuroendocrinology; 2004 Jan; 80(5):298-307. PubMed ID: 15677880
    [Abstract] [Full Text] [Related]

  • 9. Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist.
    Haugaard-Jönsson LM, Hossain MA, Daly NL, Bathgate RA, Wade JD, Craik DJ, Rosengren KJ.
    J Biol Chem; 2008 Aug 29; 283(35):23811-8. PubMed ID: 18577524
    [Abstract] [Full Text] [Related]

  • 10. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
    Kristensson L, Mayer G, Ploj K, Wetterlund M, Arlbrandt S, Björquist A, Wissing BM, Castaldo M, Larsson N.
    Eur J Pharmacol; 2015 Jan 15; 747():123-31. PubMed ID: 25496752
    [Abstract] [Full Text] [Related]

  • 11. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
    Kocan M, Sarwar M, Hossain MA, Wade JD, Summers RJ.
    Br J Pharmacol; 2014 Jun 15; 171(11):2827-41. PubMed ID: 24641548
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
    Wang JH, Shao XX, Hu MJ, Liu YL, Xu ZG, Guo ZY.
    Amino Acids; 2019 Apr 15; 51(4):619-626. PubMed ID: 30604098
    [Abstract] [Full Text] [Related]

  • 15. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
    Zhu J, Kuei C, Sutton S, Kamme F, Yu J, Bonaventure P, Atack J, Lovenberg TW, Liu C.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):43-52. PubMed ID: 18582868
    [Abstract] [Full Text] [Related]

  • 16. Identification of relaxin-3/INSL7 as a ligand for GPCR142.
    Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, Sillard R, Lovenberg TW.
    J Biol Chem; 2003 Dec 12; 278(50):50765-70. PubMed ID: 14522967
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species.
    Chen J, Kuei C, Sutton SW, Bonaventure P, Nepomuceno D, Eriste E, Sillard R, Lovenberg TW, Liu C.
    J Pharmacol Exp Ther; 2005 Jan 12; 312(1):83-95. PubMed ID: 15367576
    [Abstract] [Full Text] [Related]

  • 18. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
    Zhang WJ, Jiang Q, Wang XY, Song G, Shao XX, Guo ZY.
    J Pept Sci; 2013 Jun 12; 19(6):350-4. PubMed ID: 23526726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
    Wu H, Hoare BL, Handley TNG, Akhter Hossain M, Bathgate RAD.
    Biochem Pharmacol; 2024 Jun 12; 224():116238. PubMed ID: 38677442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.